Please enable JavaScript to continue using this application.

Compare $REPL vs $VOR | Chartloom

Compare

$REPL vs $VOR

Replimune Group Inc · Vor Biopharma Inc

REPL

Replimune Group Inc

VOR

Vor Biopharma Inc

Compare $REPL vs $VOR

Comparing Replimune Group Inc and Vor Biopharma Inc

REPLReplimune Group Inc

VORVor Biopharma Inc

REPLReplimune Group Inc

Market cap

$1.13B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

40.24x

Rev growth (TTM)

—

YTD performance

50.8%

52W performance

188.6%

FCF yield

-24.9%

VORVor Biopharma Inc

Market cap

$1.08B

P/E (TTM)

1.72x

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

71.0%

52W performance

-40.4%

FCF yield

-13.1%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

REPL

VOR

Detailed metrics comparison

REPL

Replimune Group Inc

VOR

Vor Biopharma Inc

Market Cap

REPL$1.13B

VOR$1.08B

Enterprise Value

REPL$1.05B

VOR$971M

Price

REPL$13.42

VOR$19.90

P/E Ratio

REPLN/A

VOR1.72x

P/S Ratio

REPL0.00x

VOR0.00x

EV/Sales

REPL0.00x

VOR0.00x

EV/EBITDA

REPL0.00x

VOR0.00x

P/B Ratio

REPL11.66x

VOR16.48x

P/FCF Ratio

REPLN/A

VORN/A

EV/FCF

REPL-3.75x

VOR-6.89x

PEG Ratio

REPLN/A

VORN/A

Forward P/E (NTM)

REPLN/A

VORN/A

Forward P/S (NTM)

REPL40.24x

VORN/A

Revenue (TTM)

REPL$0

VOR$0

Revenue Growth (YoY)

REPLN/A

VORN/A

Forward Rev Growth

REPL397.3%

VOR488.1%

Gross Margin (TTM)

REPL0.0%

VOR0.0%

Operating Margin (TTM)

REPL0.0%

VOR0.0%

EBITDA Margin (TTM)

REPL0.0%

VOR0.0%

Net Margin (TTM)

REPL0.0%

VOR0.0%

FCF Margin (TTM)

REPLN/A

VORN/A

Net Income (TTM)

REPL$-297M

VOR$628M

FCF (TTM)

REPL$-281M

VOR$-141M

EPS (TTM)

REPL-$3.07

VOR$11.56

ROE (TTM)

REPL-15932.0%

VOR-14213.0%

ROA (TTM)

REPL-9084.0%

VOR154.2%

ROIC (TTM)

REPL-10727.0%

VOR-14213.0%

Cash

REPL$185M

VOR$108M

Debt

REPL$109M

VOR$0

Net Cash/Debt

REPL$77M

VOR$108M

Current Ratio (TTM)

REPL5.23x

VOR19.15x

Quick Ratio (TTM)

REPL5.09x

VOR18.91x

Debt/Equity (TTM)

REPL1.03x

VOR0.00x

Debt/Assets (TTM)

REPL0.0%

VOR0.0%

Interest Coverage (TTM)

REPLN/A

VORN/A

Net Debt/EBITDA (TTM)

REPL0.00x

VOR0.00x

Beta

REPL0.97

VOR1.70

52W Performance

REPL188.6%

VOR-40.4%

YTD Performance

REPL50.8%

VOR71.0%

% from 52W High

REPL-17.8%

VOR-40.6%

% from 52W Low

REPL794.7%

VOR206.2%

Asset Turnover (TTM)

REPL0.00x

VOR0.00x

FCF Yield (TTM)

REPL-24.9%

VOR-13.1%

Earnings Yield (TTM)

REPL-26.3%

VOR58.2%

Dividend Yield (TTM)

REPLN/A

VORN/A

Rule of 40

REPL0.0

VOR0.0

EV/GP/RG

REPLN/A

VORN/A

Ticker research

View REPL research View VOR research

Metric	REPL Replimune Group Inc	VOR Vor Biopharma Inc
Market & Valuation
Market Cap	$1.13B	$1.08B
Enterprise Value	$1.05B	$971M
Price	$13.42	$19.90
P/E Ratio	N/A	1.72x
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	11.66x	16.48x
P/FCF Ratio	N/A	N/A
EV/FCF	-3.75x	-6.89x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	40.24x	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	397.3%	488.1%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-297M	$628M
FCF (TTM)	$-281M	$-141M
EPS (TTM)	-$3.07	$11.56
ROE (TTM)	-15932.0%	-14213.0%
ROA (TTM)	-9084.0%	154.2%
ROIC (TTM)	-10727.0%	-14213.0%
Financial Health
Cash	$185M	$108M
Debt	$109M	$0
Net Cash/Debt	$77M	$108M
Current Ratio (TTM)	5.23x	19.15x
Quick Ratio (TTM)	5.09x	18.91x
Debt/Equity (TTM)	1.03x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.97	1.70
52W Performance	188.6%	-40.4%
YTD Performance	50.8%	71.0%
% from 52W High	-17.8%	-40.6%
% from 52W Low	794.7%	206.2%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-24.9%	-13.1%
Earnings Yield (TTM)	-26.3%	58.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View REPL research	View VOR research

Valuation

P/E Ratio

VOR

1.72x

P/S Ratio

REPL

0.00x

VOR

0.00x

EV/FCF

VOR

-6.89x

REPL

-3.75x

Growth & revenue

Forward Revenue Growth

VOR

488.1%

REPL

397.3%

Profitability & performance

Gross Margin

REPL

0.0%

VOR

0.0%

ROE

VOR

-14213.0%

REPL

-15932.0%

FCF Yield %

VOR

-13.1%

REPL

-24.9%

52-Week Performance

REPL

188.6%

VOR

-40.4%

Detailed metrics comparison

REPL

Replimune Group Inc

VOR

Vor Biopharma Inc

Market Cap

REPL$1.13B

VOR$1.08B

Enterprise Value

REPL$1.05B

VOR$971M

Price

REPL$13.42

VOR$19.90

P/E Ratio

REPLN/A

VOR1.72x

P/S Ratio

REPL0.00x

VOR0.00x

EV/Sales

REPL0.00x

VOR0.00x

EV/EBITDA

REPL0.00x

VOR0.00x

P/B Ratio

REPL11.66x

VOR16.48x

P/FCF Ratio

REPLN/A

VORN/A

EV/FCF

REPL-3.75x

VOR-6.89x

PEG Ratio

REPLN/A

VORN/A

Forward P/E (NTM)

REPLN/A

VORN/A

Forward P/S (NTM)

REPL40.24x

VORN/A

Revenue (TTM)

REPL$0

VOR$0

Revenue Growth (YoY)

REPLN/A

VORN/A

Forward Rev Growth

REPL397.3%

VOR488.1%

Gross Margin (TTM)

REPL0.0%

VOR0.0%

Operating Margin (TTM)

REPL0.0%

VOR0.0%

EBITDA Margin (TTM)

REPL0.0%

VOR0.0%

Net Margin (TTM)

REPL0.0%

VOR0.0%

FCF Margin (TTM)

REPLN/A

VORN/A

Net Income (TTM)

REPL$-297M

VOR$628M

FCF (TTM)

REPL$-281M

VOR$-141M

EPS (TTM)

REPL-$3.07

VOR$11.56

ROE (TTM)

REPL-15932.0%

VOR-14213.0%

ROA (TTM)

REPL-9084.0%

VOR154.2%

ROIC (TTM)

REPL-10727.0%

VOR-14213.0%

Cash

REPL$185M

VOR$108M

Debt

REPL$109M

VOR$0

Net Cash/Debt

REPL$77M

VOR$108M

Current Ratio (TTM)

REPL5.23x

VOR19.15x

Quick Ratio (TTM)

REPL5.09x

VOR18.91x

Debt/Equity (TTM)

REPL1.03x

VOR0.00x

Debt/Assets (TTM)

REPL0.0%

VOR0.0%

Interest Coverage (TTM)

REPLN/A

VORN/A

Net Debt/EBITDA (TTM)

REPL0.00x

VOR0.00x

Beta

REPL0.97

VOR1.70

52W Performance

REPL188.6%

VOR-40.4%

YTD Performance

REPL50.8%

VOR71.0%

% from 52W High

REPL-17.8%

VOR-40.6%

% from 52W Low

REPL794.7%

VOR206.2%

Asset Turnover (TTM)

REPL0.00x

VOR0.00x

FCF Yield (TTM)

REPL-24.9%

VOR-13.1%

Earnings Yield (TTM)

REPL-26.3%

VOR58.2%

Dividend Yield (TTM)

REPLN/A

VORN/A

Rule of 40

REPL0.0

VOR0.0

EV/GP/RG

REPLN/A

VORN/A

Ticker research

View REPL research View VOR research

Metric	REPL Replimune Group Inc	VOR Vor Biopharma Inc
Market & Valuation
Market Cap	$1.13B	$1.08B
Enterprise Value	$1.05B	$971M
Price	$13.42	$19.90
P/E Ratio	N/A	1.72x
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	11.66x	16.48x
P/FCF Ratio	N/A	N/A
EV/FCF	-3.75x	-6.89x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	40.24x	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	397.3%	488.1%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-297M	$628M
FCF (TTM)	$-281M	$-141M
EPS (TTM)	-$3.07	$11.56
ROE (TTM)	-15932.0%	-14213.0%
ROA (TTM)	-9084.0%	154.2%
ROIC (TTM)	-10727.0%	-14213.0%
Financial Health
Cash	$185M	$108M
Debt	$109M	$0
Net Cash/Debt	$77M	$108M
Current Ratio (TTM)	5.23x	19.15x
Quick Ratio (TTM)	5.09x	18.91x
Debt/Equity (TTM)	1.03x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.97	1.70
52W Performance	188.6%	-40.4%
YTD Performance	50.8%	71.0%
% from 52W High	-17.8%	-40.6%
% from 52W Low	794.7%	206.2%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-24.9%	-13.1%
Earnings Yield (TTM)	-26.3%	58.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View REPL research	View VOR research